Correlation Between Revolution Medicines and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Revolution Medicines and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Syndax Pharmaceuticals.
Diversification Opportunities for Revolution Medicines and Syndax Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Revolution and Syndax is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Revolution Medicines and Syndax Pharmaceuticals
Given the investment horizon of 90 days Revolution Medicines is expected to generate 0.62 times more return on investment than Syndax Pharmaceuticals. However, Revolution Medicines is 1.62 times less risky than Syndax Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 3,744 in Revolution Medicines on May 6, 2025 and sell it today you would lose (81.00) from holding Revolution Medicines or give up 2.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Revolution Medicines vs. Syndax Pharmaceuticals
Performance |
Timeline |
Revolution Medicines |
Syndax Pharmaceuticals |
Revolution Medicines and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revolution Medicines and Syndax Pharmaceuticals
The main advantage of trading using opposite Revolution Medicines and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.Revolution Medicines vs. Relay Therapeutics | Revolution Medicines vs. Stoke Therapeutics | Revolution Medicines vs. Pliant Therapeutics | Revolution Medicines vs. Black Diamond Therapeutics |
Syndax Pharmaceuticals vs. Kura Oncology | Syndax Pharmaceuticals vs. Protagonist Therapeutics | Syndax Pharmaceuticals vs. Merus BV | Syndax Pharmaceuticals vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |